Bibliograph

Vaccines as technology, innovation, barriers, and the public health, Ana Santos Rutschman

Type

Label

Vaccines as technology, innovation, barriers, and the public health, Ana Santos Rutschman

Language

eng

Index

index present

Literary Form

non fiction

Main title

Vaccines as technology

Medium

electronic resource

Nature of contents

dictionaries

Oclc number

1313666084

Responsibility statement

Ana Santos Rutschman

Series statement

Cambridge Social Sciences eBooks

Sub title

innovation, barriers, and the public health

Summary

The COVID-19 pandemic served as a powerful wake-up call, highlighting our collective need for the effective development and equitable distribution of new vaccines, in addition to widespread administration of existing ones. The current models of production and allocation of vaccines against emerging pathogens, which rely on predominantly market-driven mechanisms, are largely at odds with public health needs. This book is the first to explore the entire arc of vaccine development and distribution, from the decisions about allocation of vaccine R&D money to allocation and administration of vaccines resulting from the R&D process. It explains key concepts and problems in vaccine regulation, intellectual property, technology transfer, and international relations, making complex material accessible to a non-specialist audience. Analyzing the impact of COVID-19, the book also covers several other vaccine races, as well as future directions in vaccine development and allocation.--, Provided by publisher

Table Of Contents

Vaccines as instruments of public health -- The vaccine development ecosystem -- Vaccine development under proprietary paradigms -- Access to vaccine technology -- Aligning vaccine innovation with public health needs -- Vaccines of the future : present and emerging challenges -- Conclusion: Broader implications for global public health

Creator